Last month, three of the largest insulin manufacturers announced they would take steps to reduce the price of their insulins. Eli Lilly and Company first announced it would reduce the list price for certain insulins by 70% and extend the $35 per month cap on out-of-pocket costs for people with Medicare that was enacted in...
We are only a few months into 2023, but the Endocrine Society has been busy advocating for its members. The Endocrine Society has traveled near (to Capitol Hill) and far (to Brussels and Bangkok) to advocate for our policy priorities. Our priorities include improved research, treatment, and prevention of diabetes; awareness of endocrine-related research, opportunities,...
The editors from The Journal of the Endocrine Society share their picks for the top endocrine discoveries of 2022. For Journal of the Endocrine Society editor-in-chief Zeynep Madak-Erdogen, PhD, associate professor of nutrition; Sylvia D. Stroup Scholar at the University of Illinois Urbana-Champaign, “Operation of a TCA Cycle Subnetwork in the Mammalian Nucleus” was a...
The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. This year, in addition to continuing our virtual advocacy, we had the opportunity to reintroduce several in-person advocacy activities. With help from our members, we successfully advocated for our policy priorities and raised awareness of the value...
Endocrine Society Weighs in on MPFS; Urges Congress to Avert Scheduled Medicare Cuts
Each year, the Center for Medicare and Medicaid Services (CMS) releases the Medicare Physician Fee Schedule (MPFS) rule, which outlines the agency’s payment and quality program policies for the upcoming year. Medicare policy often sets the bar for the private insurance market as well. Therefore, the payment policies and other revisions in the MPFS are...
Endocrine Society Urges Congress to Complete NIH Appropriations by December 16th Deadline
The Endocrine Society is committed to advocating for increases in the budget of the National Institutes of Health (NIH). Our Hill days, advocacy campaigns, and meetings with appropriators have contributed to increases in the NIH budget over the past seven years. Continued investment in the NIH is critical to further our understanding of endocrine disorders...
Following the mid-term congressional elections, the legislative back burner is packed with a long list of things that Democratic leadership hope to achieve during the “lame duck” session once some steam is let out from the mid-term elections’ political pressure cooker. The idea being that once control of each chamber is settled by voters, winners...
Endocrine Society Urges Congress to Avert Proposed Medicare Physician Payment Cuts
On July 7, the Center for Medicare and Medicaid Services (CMS) released the annual Medicare Physician Fee Schedule (MPFS) proposed rule. This rule outlines the agency’s proposed payment and quality program policies for the upcoming year. This year’s rule proposes several important policy changes including allowing data collection on important telehealth services provided during the...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
